Implanet

Implanet EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Implanet (ALIMP.PA) as of Oct 27, 2026 is -7.60. In the previous year, EV/EBIT (Enterprise Value to EBIT) was -6.30 — a change of 20.70% (lower).

EV/EBIT

-7.60

YoY

20.70%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Implanet is 2025 -7.60 . EV/EBIT (Enterprise Value to EBIT) of Implanet was 2024 -6.30 . It decreases by 20.70% lower compared to the previous year.

The Implanet EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBIT
Date
EV/EBIT
Jan 1, 2018
-6.20 EUR
Jan 1, 2019
-10.88 EUR
Jan 1, 2020
-12.83 EUR
Jan 1, 2021
-8.05 EUR
Jan 1, 2022
-7.83 EUR
Jan 1, 2023
-4.86 EUR
Jan 1, 2024
-6.30 EUR
Jan 1, 2025
-7.60 EUR
The Implanet EV/EBIT history
YEAREV/EBITYoY
-7.60+20.70%
-6.30+29.48%
-4.86-37.86%
-7.83-2.75%
-8.05-37.26%
-12.83+17.97%
-10.88+75.53%
-6.20+21.11%
-5.12+12.47%
-4.55+10.97%
-4.10-12.42%
-4.68+14.17%
-4.10—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Implanet Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Implanet's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Implanet's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Implanet's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Implanet grows earnings faster than its peers.

Implanet Stock analysis

What does Implanet do? Implanet SA is a French company that specializes in the manufacture and distribution of innovative medical products. The company was founded in 2007 by Ludovic Lastennet and Rémi Boyer and is headquartered in Bordeaux, France. Implanet's business model focuses on the development, production, and marketing of medical implants and instruments to support orthopedic surgeries. The company works closely with leading surgeons and healthcare facilities to find the ideal solution for patient needs. One of Implanet's main areas of expertise is the spine. The company develops various implantable products for the treatment of degenerative diseases such as scoliosis. Another important area for Implanet is orthopedics, where the company develops solutions for joint problems like knee or hip replacements. The company also creates customized implants tailored to each individual patient for maximum accuracy and effectiveness. A key aspect of Implanet's business model is adapting its products to meet customer requirements. The company collaborates closely with its customers to meet their specific needs and deliver the best possible solution. Implanet is committed to developing innovative solutions that align with surgeons' capabilities and cater to their needs. Implanet maintains partnerships and distribution agreements worldwide to sell its products and achieve market gains. The company distributes its products in the US, Europe, and Asia. To further expand its presence in these markets, Implanet collaborates closely with healthcare organizations and surgeons to ensure its products remain up-to-date and meet customer needs. Implanet strives to develop innovative solutions that revolutionize orthopedics and spine care. The company has already achieved significant success in the past with its Jazz technology, which serves as an excellent example of how the company operates in a customer-oriented and innovative manner. The Jazz technology is an implant designed for scoliosis treatment and is customized to each individual patient. Overall, Implanet has developed an innovative and customer-oriented business model that focuses on continuous product development and collaboration with surgeons and healthcare organizations. With a strong presence in the global market and a range of innovative products, the company positions itself as one of the leading providers in the field of spine care and orthopedics. Implanet is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Implanet stock

EV/EBIT (Enterprise Value to EBIT) of Implanet is -7.60 in 2025.

EV/EBIT (Enterprise Value to EBIT) of Implanet changed from -6.30 to -7.60, representing a 20.70% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) Implanet since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s Implanet with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Implanet

All Key Metrics — Implanet